Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H7NO3 |
Molecular Weight | 153.1354 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC(C(O)=O)=C(O)C=C1
InChI
InChIKey=KBOPZPXVLCULAV-UHFFFAOYSA-N
InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
Molecular Formula | C7H7NO3 |
Molecular Weight | 153.1354 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:31:32 UTC 2023
by
admin
on
Sat Dec 16 17:31:32 UTC 2023
|
Record UNII |
4Q81I59GXC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA07EC02
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
LIVERTOX |
NBK547995
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
275909
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
298109
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NDF-RT |
N0000175781
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
WHO-ATC |
A07EC02
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
253607
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C29249
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
Mesalamine
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
D019804
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
89-57-6
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
201-919-1
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
1392705
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
X-60
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
1710
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
100000091953
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
4Q81I59GXC
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
38877
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
7512
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
4075
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
SUB08782MIG
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
DTXSID5024506
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
2700
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
52582
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | RxNorm | ||
|
6775
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
MESALAZINE
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
DB00244
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
4Q81I59GXC
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
CHEMBL704
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
5444
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | |||
|
m7244
Created by
admin on Sat Dec 16 17:31:37 UTC 2023 , Edited by admin on Sat Dec 16 17:31:37 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
PARENT -> METABOLITE ACTIVE |
Inhibite the Hb-catalyzed peroxidative reaction
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 2.0
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 1.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 4.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Correction factors: for the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC |
|
||